Insulin-like growth factor II as a pharmaceutical agent in the treatment of osteopenias
US5807822A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Dec 18, 1992 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Dec 18, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an improved method of treating osteopenias, particularly osteoporosis, in mammals comprising administering a therapeutically effective amount of a pharmaceutical formulation agent comprising the polypeptide Insulin-like Growth Factor II or an osteoblastic stimulating fragment thereof, either alone or in the presence of a potentiating amount of fluoride ion, and in a pharmaceutically acceptable carrier. The invention further relates to a method of preventing osteopenias in a susceptible population of mammals consisting of administering a prophylactically effective amount of the pharmaceutical agent described above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.